Potential efficacy of vosoritide for foramen magnum stenosis in a patient with achondroplasia.
1. 系统已在2026-02-17 16:02:29对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
M Suzuki, K Sakamoto, Y Sakurai…
Pediatrics …, 2025
search.ebscohost.com
The article focuses on the therapeutic effects of vosoritide, a C-type natriuretic peptide analog, in treating achondroplasia and its associated complications, particularly foramen magnum stenosis (FMS). Vosoritide targets the overactive fibroblast growth factor receptor 3 (FGFR3) pathway, promoting bone growth and improving skeletal development in children. A case report details the treatment of a 26-month-old boy with FMS, highlighting significant improvements in his condition after starting vosoritide at 6 months old, including a reduction …
